Arginases I and II in lungs of ovalbumin-sensitized mice exposed to ovalbumin: Sources and consequences
- 1 August 2008
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 230 (3) , 269-275
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005American Journal of Respiratory and Critical Care Medicine, 2005
- Reversible and irreversible airway inflammation and fibrosis in mice exposed to inhaled ovalbuminInflammation Research, 2005
- Increased Levels of Hypoxia-sensitive Proteins in Allergic Airway InflammationAmerican Journal of Respiratory and Critical Care Medicine, 2004
- cNOS–iNOS paradigm and arginase in asthmaTrends in Pharmacological Sciences, 2003
- Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsivenessTrends in Pharmacological Sciences, 2003
- Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesisJournal of Clinical Investigation, 2003
- Viral induction of a chronic asthma phenotype and genetic segregation from the acute responseJournal of Clinical Investigation, 2002
- Exhaled Nitric Oxide after β2-agonist Inhalation and Spirometry in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen.Journal of Clinical Investigation, 1997
- o-phthaldialdehyde precolumn derivatization and reversed-phase high-performance liquid chromatography of polypeptide hydrolysates and physiological fluidsJournal of Chromatography A, 1983